Outlook Therapeutics (OTLK) Balance Sheet: Assets & Liabilities

Outlook Therapeutics (OTLK) Balance Sheet

As of Sep 30, 2025 (end of fiscal 2025), Outlook Therapeutics reported total assets of $18.58M and total liabilities of $50.77M. Shareholders' equity was negative at −$32.19M, meaning liabilities exceed assets. Total debt stood at $30.14M against $8.08M in cash and short-term investments, a net debt position of $22.05M.

Outlook Therapeutics Balance Sheet Analysis

Values in trillions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Outlook Therapeutics, Inc. (OTLK) - Annual data in trillions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017
Current Assets
Cash and Cash Equivalents	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities
Accounts Payable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Short-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.00	0.00	-	-	-	-
Accrued Liabilities	0.00	0.00	0.00	0.00	0.00	-	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	-0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accumulated Other Comprehensive Income	0.00	0.00	-32.30	0.00	-22.81	-19.73	0.00	0.00	0.00
Additional Paid-in Capital	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding	0.00	0.00	0.00	0.00	-	-	-	-	-
Total Stockholders' Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities & Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Outlook Therapeutics Balance Sheet

How much debt does Outlook Therapeutics have?

Outlook Therapeutics had total debt of $30.14M as of Sep 30, 2025, against $8.08M in cash and short-term investments. Total debt was $29.69M a year earlier.

What are Outlook Therapeutics's total assets?

Outlook Therapeutics reported total assets of $18.58M as of Sep 30, 2025, down 35.5% from $28.82M a year earlier. Total liabilities were $50.77M.

What is Outlook Therapeutics's shareholders' equity?

Outlook Therapeutics's shareholders' equity was negative at −$32.19M as of Sep 30, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition